According to Centessa Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.39. At the end of 2024 the company had a P/S ratio of 296.
Year | P/S ratio | Change |
---|---|---|
2024 | 296 | 161.23% |
2023 | 113 | |
2022 | N/A |